SNTI (STOCKS)
Senti Biosciences, Inc. Common Stock
$0.885000
+0.012100 (+1.39%)
Prev close: $0.872900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Timothy K. Lu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $28.17M
- Employees
- 48
- P/E (TTM)
- -0.28
- P/B (TTM)
- 4.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.53 | $-0.42 | -0.1092 | -25.95% |
|
Sep 2025 (Q3)
|
$-0.69 | $-0.58 | -0.1120 | -19.38% |
|
Jun 2025 (Q2)
|
$-0.56 | $-0.92 | +0.3580 | +39.00% |
|
Dec 2024 (Q4)
|
$-0.67 | $-3.19 | +2.5226 | +79.01% |
Financial Statements
| Revenues | $22.00K |
| Benefits Costs and Expenses | $61.46M |
| Costs And Expenses | $61.46M |
| Nonoperating Income/Loss | $7.34M |
| Operating Expenses | $68.80M |
| Research and Development | $37.59M |
| Other Operating Expenses | $31.22M |
| Operating Income/Loss | -$68.78M |
| Income/Loss From Continuing Operations After Tax | -$61.44M |
| Income/Loss From Continuing Operations Before Tax | -$61.44M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$61.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$61.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$61.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.73 |
| Diluted Earnings Per Share | -$2.73 |
| Basic Average Shares | 22,483,391 |
| Diluted Average Shares | 22,483,391 |
| Assets | $51.22M |
| Current Assets | $23.27M |
| Prepaid Expenses | $1.34M |
| Other Current Assets | $21.93M |
| Noncurrent Assets | $27.95M |
| Fixed Assets | $12.89M |
| Other Non-current Assets | $15.06M |
| Liabilities | $45.63M |
| Current Liabilities | $13.97M |
| Accounts Payable | $2.94M |
| Wages | $2.37M |
| Other Current Liabilities | $8.67M |
| Noncurrent Liabilities | $31.66M |
| Equity | $5.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.59M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $51.22M |
| Net Cash Flow From Operating Activities | -$43.44M |
| Net Cash Flow From Operating Activities, Continuing | -$43.44M |
| Net Cash Flow From Investing Activities | -$184.00K |
| Net Cash Flow From Investing Activities, Continuing | -$184.00K |
| Net Cash Flow From Financing Activities | $11.76M |
| Net Cash Flow From Financing Activities, Continuing | $11.76M |
| Net Cash Flow | -$31.87M |
| Net Cash Flow, Continuing | -$31.87M |
| Comprehensive Income/Loss | -$61.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$61.44M |
| Other Comprehensive Income/Loss | -$61.44M |